← Open Payments lookup

AMANDA DAVIS: Open Payments

NPI 1710637459 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$660 in 30 payments from 12 companies in 2025. Trend: 2023 $189 · 2024 $649 · 2025 $660

Food & beverage: $660
CompanyPaymentsAmount
Supernus Pharmaceuticals, Inc.4$146
Otsuka America Pharmaceutical, Inc.5$94
Corium, LLC6$89
Neurocrine BioSciences, Inc.3$81
Axsome Therapeutics, Inc.3$57
Alkermes, Inc.2$53
ABBVIE INC.2$46
Janssen Pharmaceuticals, Inc1$28
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$19
Vertical Pharmaceuticals, LLC1$16

Products named: Qelbree, Azstarys, INGREZZA, Auvelity, ARISTADA, REXULTI, VRAYLAR, SPRAVATO.

Industry payments across AL — which companies pay providers there.